Saving an additional 100 million lives

The Lancet

Volumn 391, Issue 10121, 2018, Pages 709-712

  Frieden, Thomas R ^a   Bloomberg, Michael R ^b  

^a Resolve   (United States)

^b Bloomberg LP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIHYPERTENSIVE AGENT;

ALCOHOL CONSUMPTION; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; FAT INTAKE; HEART INFARCTION; HUMAN; HYPERTENSION; MORTALITY RATE; NOTE; PHYSICAL INACTIVITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK REDUCTION; SMOKING REGULATION; SODIUM INTAKE; SODIUM RESTRICTION; TOBACCO USE; UNHEALTHY DIET; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASE; COMMUNICABLE DISEASE CONTROL; ECONOMICS; GLOBAL HEALTH; MORTALITY; PATIENT CARE; PREVENTION AND CONTROL; TRENDS;

CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; GLOBAL HEALTH; HUMANS; MORTALITY; PATIENT-CENTERED CARE; TOBACCO USE;

EID: 85029160023     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)32443-1     Document Type: Note

References (19)

1. Frieden, TR, Bloomberg, MR, How to prevent 100 million deaths from tobacco. Lancet 369 (2007), 1758–1761.
2. WHO. WHO report on the global tobacco epidemic 2017: monitoring tobacco use and prevention policies, 2017, World Health Organization, Geneva http://who.int/tobacco/global_report/en (accessed Sept 6, 2017).
3. Henning, K, Working together around the world to kick the big tobacco habit, 2017, Health Affairs Blog, Bethesda http://healthaffairs.org/blog/2017/01/05/working-together-around-the-world-to-kick-the-big-tobacco-habit (accessed Sept 6, 2017).
4. Mozaffarian, D, Katan, MB, Ascherio, A, Stampfer, MJ, Willett, WC, Trans fatty acids and cardiovascular disease. N Engl J Med 354 (2006), 1601–1613.
5. Wang, Q, Afshin, A, Yakoob, MY, et al., Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE). Impact of nonoptimal intakes of saturated, polyunsaturated, and trans fat on global burdens of coronary heart disease. J Am Heart Assoc, 5, 2016, e002891.
6. Restrepo, BJ, Rieger, M, Denmark's policy on artificial trans fat and cardiovascular disease. Am J Prev Med 50 (2016), 69–76.
7. Angell, SY, Cobb, LK, Curtis, CJ, Konty, KJ, Silver, LD, Change in trans fatty acid content of fast-food purchases associated with New York City's restaurant regulation: a pre-post study. Ann Intern Med 157 (2012), 81–86.
8. Brandt, EJ, Myerson, R, Perraillon, MC, Polonsky, TS, Hospital admissions for myocardial infarction and stroke before and after the trans-fatty acid restrictions in New York. JAMA Cardiol 2 (2017), 627–634.
9. He, FJ, Pombo-Rodrigues, S, Macgregor, GA, Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open, 4, 2014, e004549.
10. Cobb, LK, Anderson, CA, Elliott, P, et al., American Heart Association Council on Lifestyle and Metabolic Health. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation 129 (2014), 1173–1186.
11. Curtis, CJ, Clapp, J, Niederman, SA, Ng, SW, Angell, SY, US food industry progress during the National Salt Reduction Initiative: 2009–2014. Am J Public Health 106 (2016), 1815–1819.
12. Farley, TA, Dalal, MA, Mostashari, F, Frieden, TR, Deaths preventable in the US by improvements in use of clinical preventive services. Am J Prev Med 38 (2010), 600–609.
13. Mills, KT, Bundy, JD, Kelly, TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 134 (2016), 441–450.
14. Padwal, RS, Bienek, A, McAlister, FA, Campbell, NR, Outcomes Research Task Force of the Canadian Hypertension Education Program. Epidemiology of hypertension in Canada: an update. Can J Cardiol 32 (2016), 687–694.
15. Luepker, RV, Steffen, LM, Jacobs, DR Jr, Zhou, X, Blackburn, H, Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey. Circulation 126 (2012), 1852–1857.
16. Nissensohn, M, Román-Viñas, B, Sánchez-Villegas, A, Piscopo, S, Serra-Majem, L, The effect of the Mediterranean diet on hypertension: a systematic review and meta-analysis. J Nutr Educ Behav 48 (2016), 42–53.
17. Li, J, Loerbroks, A, Angerer, P, Physical activity and risk of cardiovascular disease: what does the new epidemiological evidence show?. Curr Opin Cardiol 28 (2013), 575–583.
18. Gaziano, TA, Bitton, A, Anand, S, Weinstein, MC, International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens 27 (2009), 1472–1477.
19. WHO, WEF. From burden to “best buys”: reducing the economic impact of non-communicable diseases in low- and middle-income countries, 2011, World Economic Forum, Geneva http://www.who.int/nmh/publications/best_buys_summary.pdf (accessed Sept 6, 2017).